Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/27/2023 | Inari Medical, Inc. | NARI | Exercise | Restricted Stock Unit | 3k | $0.00 | $0 | | 05/27/2023 |
05/18/2023 | Inari Medical, Inc. | NARI | Grant | Common Stock | 2.4k | $0.00 | $0 | | 05/18/2023 |
06/24/2022 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 42.1k | $8.53 | $359k | | 06/24/2022 |
06/10/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 18k | $4.18 | $75.2k | | 06/10/2022 |
05/27/2022 | Inari Medical, Inc. | NARI | Exercise | Restricted Stock Unit | 3k | $0.00 | $0 | | 05/26/2022 |
05/26/2022 | Inari Medical, Inc. | NARI | Grant | Common Stock | 2.4k | $0.00 | $0 | | 05/26/2022 |
02/25/2022 | Edgewise Therapeutics, Inc. | | Other (disposition) | Common Stock | 3.5M | $0.00 | $0 | Directly owned by USVP XI | 02/25/2022 |
12/13/2021 | ARS Pharmaceuticals, Inc. | SBTX | Other (disposition) | Common Stock | 2.1M | $0.00 | $0 | Directly owned by USVP XII | 12/13/2021 |
12/13/2021 | ARS Pharmaceuticals, Inc. | SBTX | Other (disposition) | Common Stock | 105k | $0.00 | $0 | Directly owned by USVP XII-A | 12/13/2021 |
12/02/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 7.9k | $5.68 | $44.7k | Directly owned by USVP X | 12/02/2021 |
12/02/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 252 | $5.68 | $1.4k | Directly owned by AFF X | 12/02/2021 |
12/01/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 18.6k | $6.44 | $120k | Directly owned by USVP X | 11/29/2021 |
12/01/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 597 | $6.44 | $3.8k | Directly owned by AFF X | 11/29/2021 |
11/30/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 26.6k | $6.53 | $173.5k | Directly owned by USVP X | 11/29/2021 |
11/30/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 850 | $6.53 | $5.6k | Directly owned by AFF X | 11/29/2021 |
11/29/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 25k | $6.70 | $167.1k | Directly owned by USVP X | 11/29/2021 |
11/29/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 799 | $6.70 | $5.3k | Directly owned by AFF X | 11/29/2021 |
11/26/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 4.9k | $7.01 | $34.1k | Directly owned by USVP X | 11/23/2021 |
11/26/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 156 | $7.01 | $1.1k | Directly owned by AFF X | 11/23/2021 |
11/24/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 35.4k | $7.36 | $260.3k | Directly owned by USVP X | 11/23/2021 |
11/24/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 1.1k | $7.36 | $8.3k | Directly owned by AFF X | 11/23/2021 |
11/23/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 14.4k | $7.40 | $106.7k | Directly owned by USVP X | 11/23/2021 |
11/23/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 461 | $7.40 | $3.4k | Directly owned by AFF X | 11/23/2021 |
11/22/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 25.4k | $7.86 | $199.4k | Directly owned by USVP X | 11/18/2021 |
11/22/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 812 | $7.86 | $6.4k | Directly owned by AFF X | 11/18/2021 |
11/19/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 224 | $8.12 | $1.8k | Directly owned by AFF X | 11/18/2021 |
11/19/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 7k | $8.12 | $57k | Directly owned by USVP X | 11/18/2021 |
11/18/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 16.2k | $8.53 | $138.4k | Directly owned by USVP X | 11/18/2021 |
11/18/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 519 | $8.53 | $4.4k | Directly owned by AFF X | 11/18/2021 |
11/17/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 9.9k | $9.13 | $90.5k | Directly owned by USVP X | 11/15/2021 |
11/17/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 317 | $9.13 | $2.9k | Directly owned by AFF X | 11/15/2021 |
11/16/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 8.1k | $9.42 | $75.9k | Directly owned by USVP X | 11/15/2021 |
11/16/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 257 | $9.42 | $2.4k | Directly owned by AFF X | 11/15/2021 |
11/15/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 4.9k | $9.81 | $48.2k | Directly owned by USVP X | 11/15/2021 |
11/15/2021 | eFFECTOR Therapeutics, Inc. | | Sale | Common Stock | 157 | $9.81 | $1.5k | Directly owned by AFF X | 11/15/2021 |
|